Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia.

Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.

In Wissenschaft rückt FlexChar diese Geschichte in den Mittelpunkt: A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. FlexChar zeigt sie, weil sie gerade Suche und Gespräch treibt.